# Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation

> **NCT00366691** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 40 (—)

## Conditions studied

- Cataract Extraction

## Interventions

- **DRUG:** Acular LS
- **DRUG:** Lotemax

## Key facts

- **NCT ID:** NCT00366691
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2018-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366691, "Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00366691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*